XML 35 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
Intangible Assets
12 Months Ended
Oct. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets
Intangible Assets
Goodwill
(In millions)
CooperVision
 
CooperSurgical
 
Total
Balance as of October 31, 2016
$
1,646.4

 
$
518.3

 
$
2,164.7

Net additions during the year ended October 31, 2017
28.6

 
94.4

 
123.0

Translation
60.7

 
6.4

 
67.1

Balance as of October 31, 2017
$
1,735.7

 
$
619.1

 
$
2,354.8

Net additions during the year ended October 31, 2018
36.8

 
34.4

 
71.2

Translation
(29.6
)
 
(4.3
)
 
(33.9
)
Balance as of October 31, 2018
$
1,742.9

 
$
649.2

 
$
2,392.1



Of the October 31, 2018 goodwill balance, $247.1 million for CooperSurgical and $51.8 million for CooperVision is expected to be deductible for tax purposes. Of the October 31, 2017 goodwill balance, $117.9 million for CooperSurgical and $19.7 million for CooperVision is expected to be deductible for tax purposes.
Other Intangible Assets
 
As of October 31, 2018
 
As of October 31, 2017
 
 
(In millions)
Gross
Carrying
Amount
 
Accumulated
Amortization
& Translation
 
Gross
Carrying
Amount
 
Accumulated
Amortization
& Translation
 
Weighted Average Amortization Period (In years)
Trademarks
$
139.2

 
$
16.9

 
$
44.5

 
$
10.3

 
14
Composite intangible asset
1,061.9

 
70.8

 

 

 
15
Technology
395.0

 
190.7

 
428.8

 
173.2

 
11
Customer relationships
350.0

 
168.6

 
335.5

 
145.3

 
13
License and distribution rights and other
74.9

 
52.7

 
69.2

 
44.5

 
9
 
2,021.0

 
$
499.7

 
878.0

 
$
373.3

 
14
Less accumulated amortization and translation
499.7

 
 
 
373.3

 
 
 
 
Other intangible assets, net
$
1,521.3

 
 
 
$
504.7

 
 
 
 

In the second quarter of fiscal 2018, CooperSurgical recognized an impairment charge of $24.4 million on the intangible assets acquired from Recombine Inc. as the cash flows expected to be generated by this asset group over its estimated remaining life were not sufficient to recover its carrying value. CooperSurgical acquired Recombine Inc. in fiscal 2016, a clinical genetic testing company specializing in carrier screening. The intangible assets impaired consisted of Technology, Trademark and Customer relationships.






As of October 31, 2018, the estimated future amortization expenses for intangible assets with finite lives is as follows:
Fiscal years:
(In millions)
2019
$
143.0

2020
133.3

2021
132.0

2022
130.1

Thereafter
974.0

    Total remaining amortization for intangible assets
$
1,512.4